The report on Anti-Obesity Prescription Drugs Market by Drug Class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), by Distribution Channel (retail pharmacy, hospital pharmacy and online pharmacy), and byAge Group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report identified that North America dominated the global anti-obesity prescription drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the anti-obesity prescription drugs market worldwide. The global anti-obesity prescription drugs market is driven by factors such as rising obesity concerns, substantial rise in obesity related chronic diseases and growing workload.

Get Free Sample Pages of this Premium Report:https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/1127

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global anti-obesity prescription drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.

Table of Contents:-

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3.. Global Anti-obesity Prescription Drugs Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.5. Competitive Landscape in the Global Anti-obesity Prescription Drugs Market

4. Global Anti-obesity Prescription Drugs Market by Drug Class

4.1. Orlistat

4.2. Phentermine and Topiramate

4.3. Bupropion and Naltrexone

4.4. Lorcaserin

4.5. Liraglutide

5. Global Anti-obesity Prescription Drugs Market by Distribution Channel

5.1. Retail Pharmacy

5.2. Hospital Pharmacy

5.3. Online Pharmacy

6. Global Anti-obesity Prescription Drugs Market by Age Group

6.1. Pediatric

6.2. Adult

7. Global Anti-obesity Prescription Drugs Market by Region 2018-2024

7.1. North America

7.1.1. North America Anti-obesity Prescription Drugs Market by Drug Class

7.1.2. North America Anti-obesity Prescription Drugs Market by Distribution Channel

7.1.3. North America Anti-obesity Prescription Drugs Market by Age Group

7.1.4. North America Anti-obesity Prescription Drugs Market by Country

7.2. Europe

7.2.1. Europe Anti-obesity Prescription Drugs Market by Drug Class

7.2.2. Europe Anti-obesity Prescription Drugs Market by Distribution Channel

7.2.3. Europe Anti-obesity Prescription Drugs Market by Age Group

7.2.4. Europe Anti-obesity Prescription Drugs Market by Country

7.3. Asia-Pacific

7.3.1. Asia-Pacific Anti-obesity Prescription Drugs Market by Drug Class

7.3.2. Asia-Pacific Anti-obesity Prescription Drugs Market by Distribution Channel

7.3.3. Asia-Pacific Anti-obesity Prescription Drugs Market by Age Group

7.3.4. Asia-Pacific Anti-obesity Prescription Drugs Market by Country

7.4. RoW

7.4.1. RoW Anti-obesity Prescription Drugs Market by Drug Class

7.4.2. RoW Anti-obesity Prescription Drugs Market by Distribution Channel

7.4.3. RoW Anti-obesity Prescription Drugs Market by Age Group

7.4.4. RoW Anti-obesity Prescription Drugs Market by Sub-region

8. Company Covered

8.1. F Hoffmann La Roche Ltd

8.2. Orexigen Therapeutics, Inc

8.3. Novo Nordisk A/s

8.4. Arena Pharmaceuticals, Inc

8.5. Glaxosmithkline

8.6. Vivus, Inc

8.7. Boehringer Ingelheim

8.8. Alizyme

8.9. Others

Click the Below View Full Report:- https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_anti-obesity_prescription_drugs_market